Final answer:
To select an appropriate antiHIV treatment, a genetic analysis of the HIV from the patient’s blood should be ordered to identify drug resistances and guide the choice of antiretroviral therapy.
Step-by-step explanation:
Before deciding on an antiHIV treatment for a patient with a positive Tuberculin Test, negative blood antibody tests (except for HIV), a CD4 count of 40/ml, and an HIV viral load of 750,000 copies/ml, it is imperative to perform additional laboratory tests to ensure a personalized and effective treatment strategy. Specifically, you should order a genetic analysis of the HIV from the patient's blood (Option D). This test will help identify the genotype of the HIV virus, which is crucial for determining potential drug resistances and selecting the most appropriate antiretroviral therapy. While a CBC and liver enzymes are important baseline tests, they do not provide information on the virus itself that would influence antiretroviral therapy selection. The mentioned genetic analysis informs the resistance profile of the virus and guides in the selection of a regimen that the virus is sensitive to, thus optimizing the patient's treatment outcome.